Strata Oncology pockets $26 mln Series B

Ann Arbor, Michigan-based Strata Oncology, a precision oncology platform company, has secured $26 million in Series B funding. The investors included Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management, Renaissance Venture Capital Fund, Arboretum Ventures and Baird Capital.

North AmericaUSHealthcareBriefs